Search research articles
Contact Us
Filters
Showing results (41-50 of 106) with videos related to
Page
of 11
Sort By:
Breast Cancer Research : BCR
|
January 1, 2020
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence
Fabio Conforti, Laura Pala, Eleonora Pagan, et al.
The New England Journal of Medicine
|
December 31, 2005
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer
, Beat Thürlimann, Aparna Keshaviah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2005
Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93
, Carl-Magnus Rudenstam, David Zahrieh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 14, 2007
Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial
Henning Mouridsen, Aparna Keshaviah, Alan S Coates, et al.
The Lancet. Oncology
|
October 25, 2011
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
Meredith M Regan, Patrick Neven, Anita Giobbie-Hurder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2016
Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence
Jacquie H Chirgwin, Anita Giobbie-Hurder, Alan S Coates, et al.
Breast Cancer Research : BCR
|
November 7, 2012
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX
Alan S Coates, Ewan K A Millar, Sandra A O'Toole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2015
Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial
Otto Metzger Filho, Anita Giobbie-Hurder, Elizabeth Mallon, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 17, 2007
Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group
Lorenzo Gianni, Bernard F Cole, Ilaria Panzini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2008
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials
Bernhard C Pestalozzi, David Zahrieh, Elizabeth Mallon, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 106) with videos related to
Sort By:
Page
of 11
Breast Cancer Research : BCR
|
January 1, 2020
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence
Fabio Conforti, Laura Pala, Eleonora Pagan, et al.
The New England Journal of Medicine
|
December 31, 2005
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer
, Beat Thürlimann, Aparna Keshaviah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2005
Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93
, Carl-Magnus Rudenstam, David Zahrieh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 14, 2007
Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial
Henning Mouridsen, Aparna Keshaviah, Alan S Coates, et al.
The Lancet. Oncology
|
October 25, 2011
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
Meredith M Regan, Patrick Neven, Anita Giobbie-Hurder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2016
Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence
Jacquie H Chirgwin, Anita Giobbie-Hurder, Alan S Coates, et al.
Breast Cancer Research : BCR
|
November 7, 2012
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX
Alan S Coates, Ewan K A Millar, Sandra A O'Toole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2015
Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial
Otto Metzger Filho, Anita Giobbie-Hurder, Elizabeth Mallon, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 17, 2007
Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group
Lorenzo Gianni, Bernard F Cole, Ilaria Panzini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2008
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials
Bernhard C Pestalozzi, David Zahrieh, Elizabeth Mallon, et al.
Page
of 11